Company: Cipla Ltd

Shares of Cipla Ltd fell as much as 3.5 per cent to Rs 500.25 on Thursday morning. The drugmaker posted a 6 per cent jump in June-quarter profit to Rs
Aug. 8, 2019, 12:16 p.m.

The drug maker had set up a separate company with private equity investment in FY2016 to tap the fast growing over the counter medicine portfolio
Aug. 7, 2019, 7:05 p.m.

The company had posted a net profit of ₹445.61 crore in the year-ago period, Cipla said in a filing to BSE.The company received EIR for the Kurkumbh plant for the inspection by the USFDA from March 11-20, 2019, Cipla said
Aug. 7, 2019, 4:32 p.m.

Aug. 7, 2019, 4:01 p.m.

Aug. 7, 2019, 4:01 p.m.

Apart from these firms, Lupin, Aurobindo Pharma, and HPCL will also announce their Q1 results today.
Aug. 7, 2019, 9:41 a.m.

On yoy basis, higher N. American and Indian revenues would aid ~33% yoy EBITDA growth.
Aug. 6, 2019, 4:04 p.m.

In its second deal in about two week weeks, drugmaker Cipla has forged an exclusive partnership with biopharmaceutical company, Alvotech, for the comm
July 29, 2019, 9:02 p.m.

Under the partnership, Alvotech will be responsible for the development and supply of the product, while Cipla Gulf will be responsible for registration and commercialization.
July 29, 2019, 9:10 a.m.

In India, the company said it will focus on therapeutic segments like diabetes, dermatology, cardiology and women's health
July 28, 2019, 11 a.m.